Kota Bokuda

Dr. Kota Bokuda

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Clinical Neurophysiology
Verified
Journal Article
Closed access
KBKota Bokuda
Kota Bokuda
TSToshio Shimizu
Toshio Shimizu
HKHideki Kimura
Hideki Kimura
RMRyo Morishima
Ryo Morishima
TKTsutomu Kamiyama
Tsutomu Kamiyama
EIEiji Isozaki
Eiji Isozaki

21 January 2016 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
KBKota Bokuda
Kota Bokuda
TSToshio Shimizu
Toshio Shimizu
KIKazuhiro Imamura
Kazuhiro Imamura
AKAkihiro Kawata
Akihiro Kawata
KWKazuhiko Watabe
Kazuhiko Watabe
INImaharu Nakano
Imaharu Nakano

19 August 2016 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
KBKota Bokuda
Kota Bokuda
TSToshio Shimizu
Toshio Shimizu
HKHideki Kimura
Hideki Kimura
TYToshihiro Yamazaki
Toshihiro Yamazaki
TKTsutomu Kamiyama
Tsutomu Kamiyama
EIEiji Isozaki
Eiji Isozaki

31 January 2015 in Neurology and Clinical Neuroscience
Verified
Journal Article
Open access
PDF file
MMMasako Mukai
Masako Mukai
Kiminobu SugayaKiminobu Sugaya
Kiminobu Sugaya
TOTadashi Ozawa
Tadashi Ozawa
YGYu‐Ichi Goto
Yu‐Ichi Goto
AYAkira Yagishita
Akira Yagishita
INImaharu Nakano
Imaharu Nakano
Stroke‐like episode represents a clinical hallmark of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes are usually suspected based on clinical symptoms, such as lactic acidosis, deafness, diabetes, short stature, myopathy, and cognitive decline, often with a maternal inheritance pattern of family history. We describe an elderly woman with recurrent stroke‐like episodes, who had only a faint concomitant signs, but no family history of mitochondrial disease. Sequence analysis of the mitochondrial genome extracted from biopsied muscle showed a heteroplasmic 10158T>C mutation in the mitochondrial complex I subunit gene, MT‐ND3. This is the first adult‐onset case harboring the m.10158T>C mutation, which is known to cause lethal infant‐onset Leigh syndrome. The unique manifestations of sporadic, elderly‐onset, and isolated stroke‐like episodes suggest that it is an important differential diagnosis for ischemic stroke and extend the clinical and mutational spectrum of mitochondrial stroke‐like episodes.

18 July 2013 in Case Reports in Neurological Medicine
Verified
Journal Article
Open access
PDF file
TKTeppei Komatsu
Teppei Komatsu
KBKota Bokuda
Kota Bokuda
TSToshio Shimizu
Toshio Shimizu
TKTetsuo Komori
Tetsuo Komori
RKReiji Koide
Reiji Koide
Lambert-Eaton myasthenic syndrome (LEMS) is a rare presynaptic disorder of the neuromuscular junction in association with cancer and subsequently in cases in which no neoplasm has been detected (O’Neill et al., 1988). The diagnosis of LEMS is based on the combination of fluctuating muscle weakness, diminished or absent reflexes, and a more than 60% increment of compound muscle action potential (CMAP) amplitude after brief exercise or 50 Hz stimulation for 1 s in a repetitive nerve stimulation (RNS) test (Oh et al., 2005). On the other hand, needle electromyography (EMG) findings related to LEMS have not been well described. Here, we report a case of LEMS, which showed apparent myopathic changes in needle EMG findings. Furthermore, we retrospectively examined the needle EMG findings in 8 patients with LEMS. In six of the 8 patients, the EMG findings showed myopathy-like findings. Although the findings of needle EMG indicated myopathic changes at a glance, the motor unit potential (MUP) returned to normal after a sustained strong muscle contraction. We propose the name “pseudomyopathic changes” for this phenomenon.

21 November 2012 in BMC Neurology
Verified
Journal Article
Open access
PDF file
KBKota Bokuda
Kota Bokuda
Kiminobu SugayaKiminobu Sugaya
Kiminobu Sugaya
STShunichiro Tamura
Shunichiro Tamura
KMKazuhito Miyamoto
Kazuhito Miyamoto
SMShiro Matsubara
Shiro Matsubara
TKTakashi Komori
Takashi Komori
Background: The autophagic vacuolar myopathies (AVM) are a group of inherited myopathies defined by the presence of autophagic vacuoles in pathological muscle specimens. AVM can be categorized into three groups: acid maltase deficiency, myopathies characterized by autophagic vacuoles with unique sarcolemmal features, and rimmed vacuolar myopathies (RVM). While the pathogeneses of these conditions are still being elucidated, some drugs (e.g., chloroquine, its analog, hydroxychloroquine, and colchicine) can also cause AVM. Minocycline is a disease-modifying anti-rheumatic drug that may be used in the treatment of rheumatoid arthritis (RA). Here, we describe the first case of minocycline-associated AVM with rimmed vacuole formation. Case presentation: A 75-year-old woman suffering from RA has been continuously treated with minocycline (200 mg/day) for the past 7 years. During this time, she developed a myopathy that predominantly affected her lower limbs. Histological studies of biopsied muscle revealed scattered atrophic myofibers with rimmed vacuoles that contained pigment granules. Histochemical staining revealed that the pigment comprised both iron and melanin, which is consistent with type II minocycline-induced cutaneous pigmentation. Under electron microscopy, autophagic vacuoles were consistently observed in association with numerous collections of pigment granules. Conclusions: This is the first report of minocycline-induced pigmentation in skeletal muscle. The strong association between autophagic vacuoles and the accumulation of minocycline-induced pigments suggest that long-term minocycline treatment induced pigment accumulation, leading to elevation of autophagic activity and RVM. It might also be possible that minocycline directly activated autophagy, as the observed pigments are known to form complexes containing minocycline and/or its metabolites. As long-term minocycline treatment is expected to be used more widely in the future, we must draw attention to this adverse effect.